SE460788B - Piperazinderivat, foerfarande foer framstaellning av dessa och farmaceutisk komposition med stimulerande, skyddande och/eller korrigerande verkan paa hjaernfunktionerna - Google Patents

Piperazinderivat, foerfarande foer framstaellning av dessa och farmaceutisk komposition med stimulerande, skyddande och/eller korrigerande verkan paa hjaernfunktionerna

Info

Publication number
SE460788B
SE460788B SE8300987A SE8300987A SE460788B SE 460788 B SE460788 B SE 460788B SE 8300987 A SE8300987 A SE 8300987A SE 8300987 A SE8300987 A SE 8300987A SE 460788 B SE460788 B SE 460788B
Authority
SE
Sweden
Prior art keywords
group
phenyl
formula
compounds
hydroxy
Prior art date
Application number
SE8300987A
Other languages
English (en)
Swedish (sv)
Other versions
SE8300987L (sv
SE8300987D0 (sv
Inventor
A Platel
A Lacour
G Bourgery
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE8300987D0 publication Critical patent/SE8300987D0/xx
Publication of SE8300987L publication Critical patent/SE8300987L/xx
Publication of SE460788B publication Critical patent/SE460788B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
SE8300987A 1982-02-26 1983-02-23 Piperazinderivat, foerfarande foer framstaellning av dessa och farmaceutisk komposition med stimulerande, skyddande och/eller korrigerande verkan paa hjaernfunktionerna SE460788B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203256A FR2522325B1 (fr) 1982-02-26 1982-02-26 Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
SE8300987D0 SE8300987D0 (sv) 1983-02-23
SE8300987L SE8300987L (sv) 1983-08-27
SE460788B true SE460788B (sv) 1989-11-20

Family

ID=9271396

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300987A SE460788B (sv) 1982-02-26 1983-02-23 Piperazinderivat, foerfarande foer framstaellning av dessa och farmaceutisk komposition med stimulerande, skyddande och/eller korrigerande verkan paa hjaernfunktionerna

Country Status (16)

Country Link
US (1) US4639452A (de)
JP (1) JPS58159484A (de)
AU (1) AU1188983A (de)
BE (1) BE896009A (de)
CA (1) CA1246076A (de)
CH (1) CH657615A5 (de)
DE (1) DE3306302A1 (de)
ES (2) ES8403881A1 (de)
FR (1) FR2522325B1 (de)
GB (4) GB2116967B (de)
GR (1) GR77936B (de)
IT (1) IT1193684B (de)
LU (1) LU84658A1 (de)
NL (1) NL8300720A (de)
SE (1) SE460788B (de)
ZA (1) ZA831134B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
GB8530602D0 (en) * 1985-12-12 1986-01-22 Fujisawa Pharmaceutical Co Heterocyclic compounds
EP0240233B1 (de) * 1986-03-29 1991-01-23 Suntory Limited Derivate vom Benzoquinonylphenylalkansäure-Amid
MY102447A (en) * 1986-06-16 1992-06-30 Ciba Geigy Ag Disubtituted piperazines
US5232923A (en) * 1988-03-18 1993-08-03 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives and pharmaceutical preparations containing same
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US6677343B2 (en) * 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
WO2004046110A1 (ja) * 2002-11-15 2004-06-03 Yamanouchi Pharmaceutical Co., Ltd. メラニン凝集ホルモン受容体拮抗剤
ZA200507486B (en) * 2003-03-07 2007-03-28 Astellas Pharma Inc Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
JP5025266B2 (ja) * 2004-09-01 2012-09-12 アステラス製薬株式会社 ピペリジン誘導体又はその製薬学的に許容される塩
CN101754957A (zh) 2007-07-19 2010-06-23 弗·哈夫曼-拉罗切有限公司 新的杂环基化合物和它们作为趋化因子拮抗剂的用途
CN101591310B (zh) * 2008-12-19 2012-03-21 王绍杰 一种马来酸桂哌齐特的制备方法
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN101906085B (zh) * 2009-06-04 2013-12-11 天津药物研究院 治疗心脑血管疾病的化合物、组合物、制备方法及用途
CN101921247B (zh) * 2009-06-12 2016-04-20 福州璐珈医药科技有限公司 1-(肉桂酰基)-4-哌啶基酰胺哌嗪化合物及其制备方法
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058134A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CA2844310A1 (en) 2011-08-19 2013-02-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
TW201317213A (zh) 2011-09-16 2013-05-01 Merck Sharp & Dohme 腎外髓質鉀通道抑制劑
US8999991B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771005B1 (de) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
EP2773351B1 (de) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
EP2773199B1 (de) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
EP2790511B1 (de) 2011-12-16 2016-09-14 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
WO2014085210A1 (en) 2012-11-29 2014-06-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014099633A2 (en) 2012-12-19 2014-06-26 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2956142B1 (de) 2013-02-18 2017-09-20 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US9765074B2 (en) 2013-03-15 2017-09-19 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP3027625B1 (de) 2013-07-31 2018-05-30 Merck Sharp & Dohme Corp. Zur behandlung von unter anderem bluthochdruck und akuter oder chronischer herzinsuffizienz geeignete spirokondensierte derivate von piperidin
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139934A (en) * 1966-08-18 1969-01-15 Delalande Sa Cinnamylpiperazine preparations
GB1168108A (en) * 1967-09-29 1969-10-22 Delalande Sa Amide Derivatives of 1-Piperazine Acetic Acid and Process for their Preparation
GB1218591A (en) * 1968-04-03 1971-01-06 Delalande Sa Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation
FR2068407A6 (de) * 1969-10-17 1971-08-27 Delalande Sa
US3753984A (en) * 1971-05-26 1973-08-21 Delalande Sa Amides derived from the esters of 1-piperazine propionic acid, their method of preparation and their application to therapeutics
FR2262521A1 (en) * 1973-08-08 1975-09-26 Delalande Sa 3-(3,4,5-Trimethoxyphenyl)piperazines - with coronary vasodilator, hypotensive, antiinflammatory, analgesic, and antiulcer activity
FR2244518A1 (en) * 1973-08-10 1975-04-18 Delalande Sa N-sinapyl-N'-alkoxyalkyl or-aminocarbonylmethyl-piperazines - as vasodilators, diuretics, antihypertensive and antiulcer agents
FR2240734A1 (en) * 1973-08-13 1975-03-14 Delalande Sa N-(dihydro sinapyl) piperazine derivs - having antiulcer, hypertensive and diuretic props
SE7510153L (sv) * 1974-09-12 1976-05-07 American Cyanamid Co Alkanolaminer
GB1473262A (en) * 1974-11-20 1977-05-11 Delalande Sa Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application
JPS5210284A (en) * 1975-07-11 1977-01-26 Tanabe Seiyaku Co Ltd Process for preparing piperazine derivatives
US4166116A (en) * 1977-11-11 1979-08-28 Canadian Patents And Development Limited Pharmaceutical compositions containing piperazinyl acylhydroxamic acid derivatives to treat inflammation or anaphylactic allergy conditions
JPS5732255A (en) * 1980-08-05 1982-02-20 Kowa Co Trimethoxyphenyl derivative

Also Published As

Publication number Publication date
JPH0518830B2 (de) 1993-03-15
GB8517122D0 (en) 1985-08-14
GB8517121D0 (en) 1985-08-14
US4639452A (en) 1987-01-27
GB2163151B (en) 1986-07-23
GB8517123D0 (en) 1985-08-14
IT8319764A0 (it) 1983-02-25
AU1188983A (en) 1983-09-01
FR2522325B1 (fr) 1985-08-09
JPS58159484A (ja) 1983-09-21
GR77936B (de) 1984-09-25
GB2116967A (en) 1983-10-05
GB8304846D0 (en) 1983-03-23
GB2163153A (en) 1986-02-19
ZA831134B (en) 1983-11-30
GB2163152B (en) 1986-07-23
IT1193684B (it) 1988-07-21
DE3306302C2 (de) 1992-04-02
GB2163152A (en) 1986-02-19
ES8500254A1 (es) 1984-10-01
LU84658A1 (fr) 1984-11-08
ES520089A0 (es) 1984-04-16
SE8300987L (sv) 1983-08-27
CA1246076A (en) 1988-12-06
GB2116967B (en) 1986-07-16
ES8403881A1 (es) 1984-04-16
SE8300987D0 (sv) 1983-02-23
DE3306302A1 (de) 1983-09-08
BE896009A (fr) 1983-08-24
GB2163151A (en) 1986-02-19
GB2163153B (en) 1986-07-16
FR2522325A1 (fr) 1983-09-02
CH657615A5 (fr) 1986-09-15
NL8300720A (nl) 1983-09-16
ES529265A0 (es) 1984-10-01

Similar Documents

Publication Publication Date Title
SE460788B (sv) Piperazinderivat, foerfarande foer framstaellning av dessa och farmaceutisk komposition med stimulerande, skyddande och/eller korrigerande verkan paa hjaernfunktionerna
JP2760903B2 (ja) 異項環置換アシルアミノチアゾール
JP4638560B2 (ja) 環式および複素環式のＮ−置換α−イミノヒドロキサム酸およびカルボン酸
EP1469851B1 (de) Melanocortinrezeptoragonisten
ES2276530T3 (es) Azabiciclos qu4e modelan la inhibicion de la adherencia celular.
Lindberg et al. Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by. alpha.-amino acid esters of phenethyl alcohols
JP2562503B2 (ja) プロペノンオキシムエーテル類、その製造方法、並びにこれを含有する調剤組成物
SE452459B (sv) Indol-5-metansulfonamid, en farmaceutisk komposition och ett forfarande for framstellning av foreningen
CN1011784B (zh) 制备抗过敏和抗支气管痉挛药n-二苯甲基二氮杂环烷基烷基n-酰苯胺的方法
KR20080066925A (ko) 항말라리아 제제로서 피페라진 유도체
El-Sayed et al. Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido [1, 6-a] azepine derivatives
US3644403A (en) 3-substituted-1-phenyl-indolines
US5036098A (en) Butynylamine derivatives and their production
JPH072770A (ja) 新規な置換インドール類、その製造法及びそのインドール類を含有する製剤組成物
PT89089B (pt) Processo de preparacao de derivados de alquilaminas substituidas e de composicoes farmaceuticas que os contem
JPH11513376A (ja) 選択的β▲下３▼−アドレナリン作動剤
US3592824A (en) 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
PT79375B (fr) Nouveaux benzenesulfonamides n-cyclise leur procede de preparation et leur utilisation comme substance active de compositions pharmaceutiques
BRPI0417469B1 (pt) Bifenil carboxamidas substituídas com n-aril piperidina, composição farmacêutica que os compreende e processo de preparação destes
EP0406739A2 (de) Piperidin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
US3935214A (en) 2-or 3 keto-3-or-2-phenyl-1,4-disubstituted piperazines
US5317026A (en) Acetamide derivative and application thereof
US3317560A (en) Indol-3-yl alkylguanidine derivatives
US4173636A (en) Decahydroquinolines, pharmaceutical compositions and methods of use

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8300987-8

Effective date: 19940910

Format of ref document f/p: F